http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2355814-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21c08c0f5b7157094b9165e9c2ec46f1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-14
filingDate 2001-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c4ebc193e1bb8151702b54639f359d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_503d14d5bcc551985dbadb46aa2d989a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc97ea7f657a4ecf4c0133e05983d01a
publicationDate 2010-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2355814-C
titleOfInvention Pharmaceutical composition for ophthalmic use
abstract An ophthalmic pharmaceutical composition comprising trehalose as an effective ingredient and a pharmaceutically--acceptable carrier. The pharmaceutical composition is a safe, long-term continuously-administrable, therapeutic and/or prophylactic agent for the ophthalmologic clinical symptoms and signs in Sjögren syndrome.
priorityDate 2000-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454671007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447756586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426484532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448540569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419562799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10925912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425188129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447980235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7427

Total number of triples: 57.